BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
JONE
Jones Ventures Intl Acquisition1
There isn't enough reported data to score JONE yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
JONE Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| N/A | |
| N/A |
JONE's profitability is currently weak. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like JONE.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
JONE PE Valuation
JONE has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
JONE Forward outlook
There aren't enough analyst estimates for JONE to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus JONE down 129%.
JONE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2018 | -$1.25 | +$3.04 |
| Q1 2018 | -$3.01 | +$0.92 |
| Q4 2017 | -$2.75 | +$0.50 |
| Q3 2017 | -$4.71 | -$2.79 |
| Q2 2017 | -$4.29 | -$3.54 |
| Q1 2017 | -$3.93 | -$3.12 |
| Q4 2016 | -$3.25 | -$1.94 |
| Q3 2016 | -$1.92 | -264% |
JONE lost $1.25 per share over the past year, a smaller loss than the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus down 100% for JONE.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
JONE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2018 | $53.9M | -1.1% |
| Q3 2018 | $59.7M | +35% |
| Q2 2018 | $65.3M | +34% |
| Q1 2018 | $57.5M | +39% |
| Q4 2017 | $54.5M | +38% |
| Q3 2017 | $44.2M | +33% |
| Q2 2017 | $48.6M | +67% |
| Q1 2017 | $41.2M | +59% |
JONE's revenue has slid since its 2014 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2018 | -2506% | -2494 points |
| Q3 2018 | -11% | +13 points |
| Q2 2018 | -7.5% | +376 points |
| Q1 2018 | -15% | +18 points |
| Q4 2017 | -12% | +46 points |
| Q3 2017 | -24% | +38 points |
| Q2 2017 | -383% | -292 points |
| Q1 2017 | -33% | +99 points |
JONE's operating margin was −2506% last quarter, down 2494 points from the same quarter a year ago, near the bottom of its range since 2013.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the stronger cash trend. Its trailing FCF is up 119% versus its history, compared with JONE at down 103%.
JONE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2018 | $18.8M | +7% |
| Q3 2018 | -$1.8M | -109% |
| Q2 2018 | $7.2M | -6.1% |
| Q1 2018 | $39.6M | +195% |
| Q4 2017 | $17.6M | +65% |
| Q3 2017 | $19.8M | +127% |
| Q2 2017 | $7.7M | -29% |
| Q1 2017 | $13.4M | +$18.1M |
JONE's free cash flow was −$2M over the past year, against $84M the year before. Free cash flow isn't a meaningful measure for financial services companies like JONE.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over JONE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
JONE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +1.2M shares |
| 1 year | +44% | +28.3M shares |
| 3 years | +299% | +69.1M shares |
JONE has 92M diluted shares, up 44% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $35.2M |
| Q4 2018 | $35.2M |
| Q3 2018 | $54.4M |
| Q2 2018 | $83M |
| Q1 2018 | $231.1M |
| Q4 2017 | $14M |
| Q3 2017 | $776,000 |
| Q2 2017 | $2.5M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
JONE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2018 | 7.6x | High |
| Q2 2018 | 8.7x | High |
| Q1 2017 | 20.6x | High |
| Q4 2016 | 9.2x | High |
| Q3 2016 | 4.2x | High |
| Q2 2016 | 2.9x | Moderate |
| Q1 2016 | 2.7x | Moderate |
| Q4 2015 | 3.4x | Elevated |
JONE's net debt is about 7.6 years of its operating earnings (EBITDA), up from 4.2 years a year ago. Net leverage isn't a meaningful measure for financial services companies like JONE.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
JONE Weekly Momentum
As of the close on Nov 12, 2026: $9.84.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
JONE PE vs Financial Services Sector
JONE has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
JONE has stronger trend alignment. BAC is above 1 of 5 weekly averages versus JONE above 1 of 1.
JONE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.83 | 0.1% above |
JONE is in an uptrend: it's above all one of its weekly moving averages, and 0.1% above its 8-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
JONE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $9.82 | $9.84 | +0.2% |
JONE has the edge over BAC on returns for 2026, with the stronger performance.